2025-05-24 - Analysis Report
Okay, here's an analysis of Natera Inc (NTRA) based on the provided data. I've formatted the report in English, focusing on key numbers and providing concise analysis points.

**Natera Inc (NTRA) Stock Analysis**

**0. Overview**

*   **Ticker:** NTRA
*   **Company:** Natera Inc.
*   **Description:** Natera Inc. is a diagnostics company focusing on cell-free DNA testing.

**1. Performance vs. S&P 500 (VOO)**

*   **NTRA Cumulative Return:** 126.76%
*   **VOO (S&P 500) Cumulative Return:** 79.81%
*   **Absolute Performance Spread:** 46.95%
*   **Spread Range (Max: 626.1, Min: -43.4):**
    *   **Current Spread:** 46.9
    *   **Relative Spread (Percentile):** 13.5

*   **Analysis:** NTRA has significantly outperformed the S&P 500. However, the relative spread percentile of 13.5 indicates that this outperformance, while substantial, is lower end of its historical range compared to VOO.

**Alpha/Beta Analysis Table**

| Year        | CAGR   | MDD    | Alpha    | Beta   | Cap(B) |
| :---------- | :----- | :----- | :------- | :----- | :----- |
| 2015-2017   | -6.0%  | 62.4%  | -31.0%   | -0.0   | 1.2    |
| 2016-2018   | 29.0%  | 80.1%  | 11.0%    | 0.1    | 1.9    |
| 2017-2019   | 159.0% | 80.1%  | 130.0%   | 1.2    | 4.6    |
| 2018-2020   | 530.0% | 80.1%  | 505.0%   | 0.6    | 13.6   |
| 2019-2021   | 356.0% | 62.9%  | 301.0%   | 0.2    | 12.8   |
| 2020-2022   | -119.0% | 62.9%  | -125.0%  | 0.3    | 5.5    |
| 2021-2023   | -482.0% | 69.9%  | -499.0%  | 1.2    | 8.6    |
| 2022-2024   | -75.0%  | 70.5%  | -92.0%   | 1.3    | 21.6   |
| 2023-2025   | 75.0%  | 72.8%  | 48.0%    | 0.9    | 20.9   |

*   **Analysis:**
    *   **CAGR:** Wide swings in annual growth, highlighting volatility. Recent years show negative CAGR followed by a rebound.
    *   **MDD:** High Maximum Drawdown values across all periods indicate significant risk and price fluctuations.
    *   **Alpha:**  Substantial alpha values (both positive and negative) confirm NTRA's performance is significantly different from the benchmark, driven by company-specific factors.
    *   **Beta:** Beta values fluctuate, suggesting a changing correlation with the market.
    *   **Cap:** Market capitalization varied a lot in the past years.

**2. Recent Stock Price Action**

*   **Current Price:** $153.32
*   **Previous Close:** $152.48
*   **Price Change:** +0.55
*   **5-Day Moving Average:** 152.94
*   **20-Day Moving Average:** 154.10
*   **60-Day Moving Average:** 148.54

*   **Analysis:**  The price is slightly above the 5-day moving average but below the 20-day moving average, suggesting a potential short-term upward trend but possible resistance ahead. The price is above 60-day moving average, which implies an upward trend in the medium term.

**3. Technical Indicators**

*   **Market Risk Indicator (MRI):** 0.37 (Low Risk)
*   **RSI:** 45.34 (Neutral)
*   **PPO:** -0.30 (Bearish)
*   **Recent (20-Day) Relative Spread Change:** +0.7 (Short-Term Increase)
*   **Expected Return:** 125.8% (Long-Term, vs. S&P 500)

*   **Analysis:**
    *   The Low MRI suggests that NTRA is considered relatively stable compared to the overall market.
    *   The RSI is neutral, indicating neither overbought nor oversold conditions.
    *   The negative PPO suggests that the short-term trend is slightly bearish.
    *   The positive change in relative spread suggests a short-term increase in outperformance compared to the S&P 500.
    *   The high Expected Return suggests the potential for substantial long-term gains. The recent small price change of +0.55 suggests that recent market activities or news have not had a dramatic impact on the stock price.

**4. Recent News & Significant Events**

*   **[2025-05-22]:** Major business developments, regulatory changes, or market events.
*   **[2025-05-24]:** Analyst discussions on recent performance and outlook.
*   **[2025-05-20]:** Stock volatility influenced by news, earnings, or executive actions.
*   **[2025-05-21]:** Mixed opinions from market experts.

*   **Analysis:** Recent news indicates that Natera is experiencing significant activity and volatility. Investors should closely monitor company announcements, earnings reports, and analyst opinions.

**5. Recent Earnings Analysis**

| 날짜       | EPS    | 매출        |
| :--------- | :----- | :---------- |
| 2025-05-09 | -0.50  | 0.50 B$     |
| 2024-11-12 | -0.26  | 0.44 B$     |
| 2024-08-09 | -0.30  | 0.41 B$     |
| 2024-05-10 | -0.56  | 0.37 B$     |
| 2025-05-09 | -0.56  | 0.37 B$     |

*   **Analysis:**
    *   NTRA is not yet profitable, as indicated by negative EPS values across all reported quarters.
    *   Revenue has generally been increasing, suggesting growth in the company's operations.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
| :----------- | :-------- | :------------ |
| 2025-03-31   | $0.50B    | 63.12%        |
| 2024-12-31   | $0.48B    | 62.94%        |
| 2024-09-30   | $0.44B    | 61.79%        |
| 2024-06-30   | $0.41B    | 58.83%        |
| 2024-03-31   | $0.37B    | 56.72%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE       |
| :----------- | :-------- | :-------- |
| 2025-03-31   | $1.24B    | -5.40%    |
| 2024-12-31   | $1.20B    | -4.50%    |
| 2024-09-30   | $0.88B    | -3.60%    |
| 2024-06-30   | $0.84B    | -4.48%    |
| 2024-03-31   | $0.79B    | -8.51%    |

*   **Analysis:**
    *   Revenue is consistently increasing, indicating growing market acceptance or expansion.
    *   Profit margins are relatively high and improving, suggesting increasing efficiency in operations.
    *   Equity has increased, indicating a strengthening financial base.
    *   Negative ROE values confirm the company's lack of profitability.

**7. 종합 Analysis**

Natera (NTRA) shows a mixed picture:

*   **Positive:** Strong historical outperformance vs. S&P 500, high expected long-term return, increasing revenue, and improving profit margins.
*   **Negative:** High historical volatility (MDD), current lack of profitability (negative EPS and ROE), and reliance on future growth to justify valuation.

**Recommendation:**  NTRA presents a high-risk, high-reward opportunity.  Investors should carefully consider their risk tolerance and conduct further due diligence, paying close attention to upcoming earnings reports, news regarding regulatory changes, and analyst updates.  The recent news indicates increased volatility, suggesting a need for caution. The high expected return suggests that NTRA may be a good investment for long-term investors who are willing to take on risk.
